These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26352555)

  • 1. INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: PHARMACOKINETIC CONSIDERATIONS.
    Yang Y; Bailey C; Loewenstein A; Massin P
    Retina; 2015 Dec; 35(12):2440-9. PubMed ID: 26352555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal steroids for macular edema in diabetes.
    Rittiphairoj T; Mir TA; Li T; Virgili G
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluocinolone acetonide implantable device for diabetic retinopathy.
    Schwartz SG; Flynn HW
    Curr Pharm Biotechnol; 2011 Mar; 12(3):347-51. PubMed ID: 20939799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant.
    Ciulla TA; Harris A; McIntyre N; Jonescu-Cuypers C
    Expert Opin Pharmacother; 2014 May; 15(7):953-9. PubMed ID: 24661081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency.
    Adams OE; Schechet SA; Hariprasad SM
    Eur J Ophthalmol; 2021 Mar; 31(2):612-619. PubMed ID: 31964171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
    Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
    Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid use for diabetic macular edema: old fad or new trend?
    Stewart MW
    Curr Diab Rep; 2012 Aug; 12(4):364-75. PubMed ID: 22581206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluocinolone acetonide for the treatment of diabetic macular edema.
    Veritti D; Sarao V; Diplotti L; Samassa F; Lanzetta P
    Expert Opin Pharmacother; 2017 Oct; 18(14):1507-1516. PubMed ID: 28764565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
    Batioğlu F; Ozmert E; Parmak N; Celik S
    Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
    Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.
    Pearson PA; Comstock TL; Ip M; Callanan D; Morse LS; Ashton P; Levy B; Mann ES; Eliott D
    Ophthalmology; 2011 Aug; 118(8):1580-7. PubMed ID: 21813090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the effect of intravitreal triamcinolone acetonide on diabetic macular edema dose-dependent?
    Šaric B; Šaric VB; Motušic R; Predovic J
    Eur J Ophthalmol; 2014; 24(2):221-7. PubMed ID: 24030541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone acetonide for diabetic macular edema.
    Chieh JJ; Roth DB; Liu M; Belmont J; Nelson M; Regillo C; Martidis A
    Retina; 2005; 25(7):828-34. PubMed ID: 16205559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema.
    Messenger WB; Beardsley RM; Flaxel CJ
    Drug Des Devel Ther; 2013; 7():425-34. PubMed ID: 23737661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY.
    Ong SS; Walter SD; Chen X; Thomas AS; Finn AP; Fekrat S
    Retin Cases Brief Rep; 2021 May; 15(3):261-265. PubMed ID: 30015770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema.
    Vaz-Pereira S; Castro-de-Sousa JP; Martins D; Prates Canelas J; Reis P; Sampaio A; Urbano H; Kaku P; Nascimento J; Marques-Neves C
    Ophthalmic Res; 2020; 63(2):114-121. PubMed ID: 31801148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema.
    Elbendary AM; Shahin MM
    Retina; 2011 Nov; 31(10):2058-64. PubMed ID: 21765371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.